|
Sleep Disorder (Sedative-Hypnotic) Drug Information
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks. These risks include severe allergic reactions and complex sleep-related behaviors, which may include sleep-driving. Sleep driving is defined as driving while not fully awake after ingestion of a sedative-hypnotic product, with no memory of the event.
Drugs
- Ambien, Ambien CR (zolpidem tartrate)
- Butisol sodium
- Carbrital (pentobarbital and carbromal)
- Dalmane (flurazepam hydrochloride)
- Doral (quazepam)
- Halcion (triazolam)
- Lunesta (eszopiclone)
- Placidyl (ethchlorvynol)
- Prosom (estazolam)
- Restoril (temazepam)
- Rozerem (ramelteon)
- Seconal (secobarbital sodium)
- Sonata (zaleplon)
 Back
to Top 
Back to Drug Info
 PDF requires the free
Adobe Acrobat Reader
Date created: March 14, 2007 |
